Edwards Lifesciences Medical Device Company Intelligence Report

Date: March 31, 2012
Pages: 36
Price:
US$ 515.00
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: EFA2B277C6FEN
Leaflet:

Download PDF Leaflet

Edwards Lifesciences Medical Device Company Intelligence Report
Edwards Lifesciences is a global provider of products and technologies that are designed to treat advanced cardiovascular disease. The company is focused specifically on technologies that treat structural heart disease and critically ill patients.

The products and technologies offered by Edwards to treat advanced cardiovascular disease are categorised into four main areas: Heart Valve Therapy, Critical Care, Cardiac Surgery Systems and Vascular.
  • Heart Valve Therapy - Edwards claims to be the leading manufacturer of tissue heart valves and repair products, which are used to replace or repair a patient’s diseased or defective heart valve. The company produces pericardial and porcine valves from biologically-inert animal tissue sewn onto proprietary wire form stents.
  • Critical Care – Edwards’ range of Critical Care products include haemodynamic monitoring equipment that is used to measure a patient's cardiovascular function, disposable pressure transducers and central venous access products for fluid and drug delivery. In September 2009, Edwards sold certain assets related to its haemofiltration product range to Baxter International.
  • Cardiac Surgery Systems – Edwards’ Cardiac Surgery Systems products include a range of products for use during cardiac surgery, including cannulae, the Embol-X intra-aortic filtration system and certain other disposable products used during cardiopulmonary bypass procedures.
  • Vascular – Edwards manufactures a variety of products used to treat vascular disease, including balloon-tipped, catheter-based embolectomy products, surgical clips and clamps.

Edwards’ global brands include Carpentier-Edwards, Cosgrove-Edwards, Edwards Sapien, FloTrac, Fogarty, Perimount Magna and Swan-Ganz. The company’s products are sold in approximately 100 countries.

Edwards is based in Irvine, California, US, and employs approximately 7,800 people worldwide. The company’s regional headquarters are located in St Prex, Switzerland; and Tokyo, Japan. In the year ended 31st December 2011, the company generated sales of US$1,679 million.

This company report provides

Overview
  • Key contact information
  • Introduction to the company and its current activities
  • Summary of its financial performance
  • Who are the company’s major competitors?
  • Key recent events in an “at a glance” format
Financial Review
  • Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
  • Table providing in-depth five-year financial analysis
  • Employee data, including breakdown by company division and geographic location
Strategic Focus
  • Investigates the company’s aims and its areas of focus
Products
  • Core product areas, key brands, product approvals and launches Research and Development
  • How much has been invested in R&D?
  • Where is the research based?
  • What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
  • Identifying the company’s manufacturing locations
  • Sales and marketing facilities
Agreements
  • With whom has the company reached agreements and what do they involve?
  • Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments

Litigation

Key Corporate Events
OVERVIEW

FINANCIAL REVIEW

2011 Financial results
Five-Year Financial Data
Outlook
Employees

STRATEGIC FOCUS

PRODUCTS

Heart Valve Therapy
  Recent Heart Valve Therapy Product News
Critical Care
  Recent Critical Care Product News
Cardiac Surgery Systems
  Recent Cardiac Surgery Systems Product News
Vascular

RESEARCH AND DEVELOPMENT

R&D Expenditure
R&D Facilities
Trial and Study Results
  PARTNER US Trial
  PARTNER II Trial
  PARTNER EU Trial
  SOURCE Registry
  Sapien Valve
  TRITON Trial
  FloTrac System
  Carpentier-Edwards Perimount Magna Ease Aortic Heart Valve
  PREVAIL TA Study
  PREVAIL Japan Study
  Port Access System
  EVOLUTION II Discontinuation

MANUFACTURING AND DISTRIBUTION

AGREEMENTS

Premier
Carmat
Philips Healthcare
Cardio Access
DexCom
Angiotech Pharmaceuticals
Medtronic
3F THERAPEUTICS
Carbomedics
Cook Biotech

MERGERS AND ACQUISITIONS

Embrella Cardiovascular
  CardioVations Division of Ethicon
  ev3’s Percutaneous Mitral Valve Repair Programme
  Percutaneous Valve Technologies
  Whitland Research
  Embol-X Embolic Management System
  Jomed’s Mitral Valve Repair System
  CardioFocus’ Surgical Business for Treating Cardiac Arrhythmias
  Japan-based Cardiovascular Joint Venture
  Research Medical
  Intramed Laboratories

MINORITY INVESTMENTS

Sphere Medical
Vascular Architects
Foundation Medical Partners
PLC Systems
WorldHeart

DIVESTITURES

Haemofiltration Product Line
LifeStent Peripheral Vascular Product Line
US Distribution Rights to TMR Laser Product
Angiogenesis Programme
Remaining Perfusion Products Business
Lifespan ePTFE Vascular Graft Business
Japanese Cardiopulmonary Business and Pacemaker Distribution Business �
Italian Perfusion Services Business
German Perfusion Services Unit
Edwards Lifesciences Cardiovascular Resources
Bentley Product Line
Novacor Left Ventricular Assist Business

LITIGATION

CoreValve (Medtronic)
Cook and W.L. Gore
Cook

KEY CORPORATE EVENTS

LIST OF TABLES

SUMMARY OPERATING RESULTS
Recent Key Events
Edwards Lifesciences – Annual Financial Results, 2007-2011
Edwards Lifesciences – Annual Revenue by Business Segment, 2007-2011
Edwards Lifesciences – Annual Revenues by Geographic Area, 2007-2011
Edwards Lifesciences – Five-Year Financial Summary, 2007-2011
Edwards Lifesciences - Forecast 2012 Sales by Product Line
Edwards Lifesciences – Heart Valve Therapy Product Summary
Edwards Lifesciences - Critical Care Product Summary
Edwards Lifesciences - Cardiac Surgery Systems Product Summary
Edwards Lifesciences - Vascular Product Summary
Edwards Lifesciences – R&D Expenditure, 2007-2011
Agreements Summary
Mergers and Acquisitions Summary

LIST OF CHARTS

Edwards Lifesciences – Annual Sales and Operating Income, 2007-2011
Edwards Lifesciences – Annual Revenue by Business Segment, 2007-2011
Edwards Lifesciences – Annual Revenues by Geographic Area, 2007-2011
Edwards Lifesciences – 2011 Sales by Business Segment
Edwards Lifesciences – Forecast R&D Expenditure, 2012
Skip to top


Ask Your Question

Edwards Lifesciences Medical Device Company Intelligence Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: